Abstract Vascular extravasation, a key step in systemic infection by hematogenous microbial pathogens, is poorly understood, but has been postulated to encompass features similar to vascular transmigration by leukocytes. The Lyme disease spirochete can cause a variety of clinical manifestations, including arthritis, upon hematogenous dissemination. This pathogen encodes numerous surface adhesive proteins (adhesins) that may promote extravasation, but none have yet been implicated in this process. In this work we report the novel use of intravital microscopy of the peripheral knee vasculature to study transmigration of the Lyme spirochete in living Cd1d-/-mice. In the absence of iNKT cells, major immune modulators in the mouse joint, spirochetes that have extravasated into joint-proximal tissue remain in the local milieu and can be enumerated accurately. We show that BBK32, a fibronectin and glycosaminoglycan adhesin of B. burgdorferi involved in early steps of endothelial adhesion, is not required for extravasation from the peripheral knee vasculature. In contrast, almost no transmigration occurs in the absence of P66, an outer membrane protein that has porin and integrin adhesin functions. Importantly, P66 mutants specifically defective in integrin binding were incapable of promoting extravasation. P66 itself does not promote detectable microvascular interactions, suggesting that vascular adhesion of B. burgdorferi mediated by other adhesins, sets the stage for P66-integrin interactions leading to transmigration. Although integrin-binding proteins with diverse functions are encoded by a variety of bacterial pathogens, P66 is the first to have a documented and direct role in vascular transmigration. The emerging picture of vascular escape by the Lyme spirochete shows similarities, but distinct differences from leukocyte transmigration.

Author Summary Lyme disease is the most common vector-transmitted infection in North America and Europe. Diverse clinical manifestations of Lyme disease result from the dissemination of the spirochetes causing the disease into a variety of tissue sites. Dissemination results from invasion of the vasculature by the bacteria, followed by exit into virtually all tissue types. The mechanism of vascular transmigration by Lyme disease spirochetes remains uncharacterized. Here we describe a novel approach to study transmigration of Lyme disease spirochetes using intravital microscopy of the peripheral knee vasculature in living mice. Our studies have identified an adhesin, P66, and its integrin-binding function as playing important roles in Lyme spirochete transmigration and dissemination.

Citation: Kumar D, Ristow LC, Shi M, Mukherjee P, Caine JA, Lee W-Y, et al. (2015) Intravital Imaging of Vascular Transmigration by the Lyme Spirochete: Requirement for the Integrin Binding Residues of the B. burgdorferi P66 Protein. PLoS Pathog 11(12): e1005333. https://doi.org/10.1371/journal.ppat.1005333 Editor: D. Scott Samuels, University of Montana, UNITED STATES Received: November 26, 2014; Accepted: November 17, 2015; Published: December 18, 2015 Copyright: © 2015 Kumar et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Data Availability: All relevant data are within the paper and its Supporting Information files. Funding: Work in the authors’ laboratories was funded by National Institutes of Health (NIH) grants R01-AI093104 (JC and GC), R01-AI084873 (JC) and by grant MOP 53086 (GC) from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html). GC was supported by a Canada Research Chair in the Molecular Biology of Lyme Borreliosis (http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx) and a Scientist Award from Alberta Innovates – Health Solutions (http://www.ahfmr.ab.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing interests: The authors have declared that no competing interests exist.

Introduction Lyme disease is a spirochetal illness caused by various members of the genus Borrelia, and the most prevalent vector-borne illness in North America and Europe [1–5]. The disease is transmitted to humans during the feeding of infected hard-shelled ticks that have acquired the spirochetes during an earlier blood meal on infected reservoir animals. Once inoculation of the skin has occurred, the highly motile Borrelia species multiply and migrate in the skin, often resulting in an erythema migrans lesion or “bulls-eye rash”. As the disease progresses (see Fig 1), spirochetes invade the vasculature, which provides a mechanism for dissemination throughout the body, followed by extravasation into a variety of tissue types. Dissemination of spirochetes can result in non-specific illness, arthralgia, carditis and neuroborreliosis. Persistent untreated infection can result in acrodermatitis and a variety of neurological problems, as well as Lyme arthritis, a common feature of the disease in North America that results from the inflammatory response to spirochete invasion into the joints [6]. PPT PowerPoint slide

PowerPoint slide PNG larger image

larger image TIFF original image Download: Fig 1. Progression of Lyme disease in humans following B. burgdorferi infection. Spirochetes are inoculated in the skin through the bite of an infected hard-shelled Ixodes tick. CNS, central nervous system; PNS, peripheral nervous system. Reprinted from Trends in Microbiology, Vol. 21, No. 8, Coburn, J., Leong, J. and Chaconas, G., Illuminating the roles of the Borrelia burgdorferi adhesins, Pages 372–379, Copyright 2013, with permission from Elsevier. [7] https://doi.org/10.1371/journal.ppat.1005333.g001 Although hematogenous dissemination is important for disease development, little is known regarding the mechanisms involved in this process. Hematogenous dissemination is a multi-step process likely involving multiple Borrelia proteins as well as host proteins and macromolecular cell receptors in the host vasculature [7, 8]. Direct analysis and quantification of the transmigration process has been complicated by a variety of factors. Generalized dissemination assays by culture of spirochetes from mouse tissues or by direct observation do not provide quantitative information [9]. More recently visualization of dissemination by whole body bioluminescent imaging [10] provides quantitative information. The above methods provide useful information, but do not reveal the causes for a lack of dissemination or the step along the transmigration pathway where defects occur. A failure to disseminate may be related to a lack of spirochete survival due to metabolic defects [11], clearance of spirochetes by the host immune system [12, 13], or a defect in one of the spirochetal components directly required for early or later steps along the transmigration pathway. We have previously used intravital microscopy to study early events in dissemination [14–16]. The high dose needle inoculation and short-term observation period precludes the use of our intravital system for investigation of many aspects of the natural infectious cycle of B. burgdorferi in mice. However, it does provide an exceedingly powerful approach for investigation of mechanistic aspects of spirochete-host interactions in their natural setting. In particular, interactions of B. burgdorferi with the host microvasculature can be imaged in real time at high resolution under shear force in a living animal. This has allowed us to effectively image B. burgdorferi interactions with post-capillary venules [14–16]. Spirochetes in the vasculature have been observed to participate in initial tethering interactions, followed by longer-lived dragging interactions and finally stationary adherence to the endothelium. These interactions can be quantitatively analyzed and mechanistically dissected. However, invasion of surrounding tissue is a rare event compared with vascular adhesion and the number of transmigrating spirochetes observed by intravital microscopy was exceedingly low during the course of one-hour experiments. Moreover, transmigrated spirochetes were highly motile in flank skin, where the experiments were performed, and rapidly escaped the site of transmigration. Therefore, enumeration of transmigration required direct observation of rare escaping spirochetes, making the use of intravital microscopy ineffective for studying this process. In the current work we report the development of a high resolution intravital imaging transmigration assay that allows enumeration of transmigrated spirochetes in the peripheral knee vasculature of living mice. In knee joint-proximal tissue in the mouse, iNKT cells surround the outside of blood vessels and block extravasation; they also eliminate those spirochetes that do successfully transmigrate into the joint-proximal tissue [17]. The use of Cd1d-/- mice, which lack iNKT cells, results in a 25-fold increase in spirochetes disseminating into the mouse joint [18], providing numbers of spirochetes amenable for direct visualization. Moreover, fluorescent transmigrated B. burgdorferi persist in the joint-proximal tissue and can be enumerated at 24 hours post intravenous (iv) inoculation. Using this new approach, coupled with an analysis of vascular clearance, we show that B. burgdorferi lacking BBK32, an important fibronectin and glycosaminoglycan adhesin [7, 19–21] display wild-type levels of transmigration. In contrast, spirochetes lacking the integrin adhesin and porin P66 [22–24] or those specifically defective in integrin binding display almost no vascular transmigration into the mouse knee joint-proximal tissue, indicating a direct role for P66-integrin interactions in the transmigration process.

Discussion In this work we report a new approach to study vascular transmigration. This approach utilizes assessment of transmigration in the mouse peripheral knee vasculature by intravital microscopy in Cd1d-/- mice. The intravital methodology allows direct visualization and enumeration of transmigrated spirochetes in living mice. The use of Cd1d-/- mice makes this assay possible by eliminating iNKT cells, a component of the innate immune response that disrupts dissemination of B. burgdorferi into mouse joints through a granzyme dependent pathway [17, 18]. The peripheral knee vasculature also provides a desirable target for observation since transmigrating spirochetes remain in the local environment, in contrast to flank skin where they rapidly leave the transmigration site [14]. The general applicability to other tissues of conclusions drawn herein from intravital data obtained from the peripheral knee vasculature is currently unknown as this work is the first reported study of spirochete transmigration using intravital microscopy and the peripheral knee vasculature currently the only location where quantitative imaging of this process is currently viable. Using intravital microscopy of Cd1d-/- mice inoculated with GFP-expressing B. burgdorferi, we have monitored the effect of two important spirochete adhesins on transmigration into the joint-proximal tissue of the mouse knee. The Fn and GAG binding protein, BBK32, is believed to be involved in early steps of the dissemination process. It is sufficient to restore microvascular interactions to a non-adherent, non-infectious, high-passage B. burgdorferi strain [16]. BBK32 mediates tethering and dragging interactions with the host microvasculature through its Fn and GAG binding domains, respectively [15]. These interactions are believed to precede transmigration. Interestingly, disruption of the gene for BBK32 did not result in a decrease in transmigration into the mouse knee joint-proximal tissue and the mutant spirochetes were not cleared significantly faster than the wild-type parent. The absence of a transmigration phenotype for the bbk32 mutant is likely the result of duplicity of function; in the absence of BBK32, an unknown Fn-independent adhesin (or adhesins) maintain microvascular interactions in the mouse peripheral knee vasculature at 50% of the wild-type level [15]. We predict that the combined disruption of both BBK32 and the unknown Fn-independent adhesin(s) would dramatically impact transmigration; however, such an experiment is precluded until the identity of the unknown Fn-independent adhesin(s) is established. It is also noteworthy that in contrast to a lack of an effect of a bbk32 mutation on transmigration by our intravital assay, it has been previously reported that a bbk32 mutation results in a decreased ability to invade joints as determined by bioluminescent imaging, qPCR and spirochete recovery by culture [10]. An explanation for the discrepancy with our results is that the previous study utilized intradermal needle inoculation of mice with 103−105 spirochetes and followed outcomes up to 14 days post-infection. Although not natural tick inoculation, this mouse model has been used for decades to study Borrelia infections. In contrast, to obtain mechanistic data on the transmigration process, we have used the reductionist approach of intravenous inoculation of 4x108 spirochetes in Cd1d-/- mice for intravital imaging of transmigration at 24 hours. Our approach seeks to identify molecules directly involved in the transmigration process and seeks to eliminate other possible roles of BBK32 in the early infection process. The variance between our results and those previously published [10] suggests that BBK32 may have other functions in the infection process in wild-type mice that our assay has sidestepped, but which are noticeable in the traditional animal model. Alternatively, the variance may result from differences in gene expression associated with host adaptation of the spirochetes within the timeframes of the two experiment [34–38]. In contrast to the BBK32 result, disruption of the gene encoding the integrin adhesin and porin, P66, resulted in a dramatic reduction in transmigration. Moreover, mutants with either alanine substitutions for the aspartic acids at position 205 and 207 or deletion of residues 202–208, also resulted in a dramatic loss of transmigration ability. The noted mutations specifically target the integrin-binding residues of P66 without affecting its porin activity [33]. Our data therefore suggest that integrin binding is an essential feature of B. burgdorferi transmigration. Analysis of the effect of p66 disruption on vascular adhesion in a low-adherence high passage strain (lacking BBK32) revealed that P66 does not promote early transient interactions or stationary adhesions. Therefore, the transmigration process appears to be temporally choreographed with adhesins such as BBK32 and the unknown fibronectin-independent adhesion(s) playing an initial role of establishing B. burgdorferi-microvascular interactions that subsequently facilitate P66-integrin communication leading to transmigration through an as yet undefined process. In agreement with the findings presented here are the recent results that the p66Δ202–208 mutant displays undetectable bacterial burdens at two weeks after iv inoculation and reduced migration across microvascular endothelial monolayers in vitro [33]. A variety of bacterial pathogens encode integrin-binding proteins (see [39, 40]). Integrin binding plays diverse roles for bacterial pathogens, including as an adherence target on host cells and extracellular matrix (ECM). Integrin binding also functions to promote pathogen-host signaling pathways that may lead to cellular invasion [39, 40]. However, a function for an integrin-binding protein in bacterial vascular transmigration has not been previously reported. The slowly emerging picture of B. burgdorferi transmigration is that it is a multi-step process involving several B. burgdorferi proteins and host molecules [14–16] and has general similarities to leukocyte transmigration [41–43], although very significant deviations exist. In both cases the process is initiated by tethering interactions that withstand the shear stress of vascular flow. In B. burgdorferi this occurs between the Fn-binding domain of BBK32 and endothelial surface localized Fn. Subsequently, rolling (leukocytes) or dragging (B. burgdorferi) occurs. In Lyme disease spirochetes the dragging stage involves additional interactions between the GAG-binding domain of BBK32 and glycosylated endothelial receptors. Thereafter, stationary adhesion occurs, which involves at least one additional spirochete factor [14–16]. Our current work suggests that P66 is involved upon the establishment of a stationary interaction, where P66-integrin interactions can occur within an established B. burgdorferi-endothelial complex. Tethering, dragging and stationary B. burgdorferi interactions can be observed within minutes of iv spirochete injection. However, transmigration occurs only at background levels until about 24 hours after iv injection. The velocity of B. burgdorferi in liquid or 2–3% gelatin is about 3.5–5 μm per second [44, 45]. The rate of forward motion of spirochetes escaping postcapillary venules is much slower, about 3.4 μm per minute. Even at this slower velocity the average time span of spirochetal escape is about 11 minutes [14]. This raises the question of why only background levels of transmigration occur until 24 hours post-inoculation when both adhesion and physical escape can occur within a much shorter time-frame. A possible explanation for this that there may be a requirement for stationary B. burgdorferi adhesions to promote localized endothelial activation resulting in an increased permeability of the endothelium that facilitates spirochete transmigration. Conversely, stable adherence of B. burgdorferi to the endothelium may promote activation of the spirochete by inducing the production of factors that are necessary for transmigration. In the case of leukocytes, activation of integrins precedes an increase in ligand affinity, resulting in stationary adhesion and migratory arrest on the endothelial surface, although integrins also play other roles in leukocyte transmigration [41–43]. In contrast, B. burgdorferi does not contain integrins, but encodes P66, an integrin adhesin and porin. We show here that the integrin-binding region of P66 is required for transmigration into the mouse knee joint-proximal tissue. Whether the porin activity is also required for transmigration remains unknown at present since P66 mutants affecting the porin but not the integrin-binding activity do not currently exist. The mechanism by which P66 is involved in the transmigration process awaits further characterization. Finally, it is important to note that the intravital imaging studies reported here provide a powerful tool for studying the role of P66 in vascular interactions and transmigration, however, they do not shed light on other roles of P66 in the natural infectious process as recently reported [33]. The work reported here describes a new approach to study vascular transmigration of the Lyme disease spirochete, which has resulted in the identification of the first B. burgdorferi adhesin believed to be directly involved in vascular transmigration.

Materials and Methods Ethics statement and use of mice All animal experimentation was carried out in accordance with the principles outlined in the most recent policies and Guide to the Care and Use of Experimental Animals by the Canadian Council on Animal Care. The animal protocol (AC12-0218) was approved by The Animal Care Committee of the University of Calgary. Wild-type BALB/c mice were purchased from Charles River (Wilmington, MA) and CD1d-/- mice in a BALB/c background (Jax #2962) were bred in-house at the Clara Christie Centre for Mouse Genomics at the University of Calgary. Mice of both genders between 5–16 weeks of age were used. Bacterial strains and culture The GFP-expressing B. burgdorferi strains used in this study are described in S1 Table. pTM61-strep (SmR/SpR) was constructed by digesting pTM61 [14] with AvrII and MluI (New England Biolabs, Beverly, MA), then dephosphorylated using alkaline phosphatase. The spectinomycin/streptomycin resistance cassette [46] was amplified from pTAspc (provided by Dr. D. Scott Samuels) using the primers flgBpAvrII (CCTAGGTAATACCCGAGCTTCAAGGAAG) and aadAMluI (ACGCGTGACGTCATTATTTGCCGACTACC). The PCR product was cloned directly in pGEM T Easy (Promega, Madison, WI), then excised with AvrII and MluI and ligated into the pTM61 prepared as described above. The ligation mixes were used to transform E. coli strain Top10 (Life Technologies, Grand Island, NY) by electroporation [47]. Selection of the desired recombinant plasmid was performed by plating on Luria broth agar supplemented with spectinomycin at 80 μg/ml. For further experiments in B. burgdorferi, the plasmid was selected for using 80 μg/ml of streptomycin in Barbour-Stoenner-Kelly II (BSK-II) medium (with 6% rabbit serum, Cedarlane Laboratories ltd., Burlington, ON). Plasmid content was analyzed for all constructed strains by multiplex PCR [48]. Spirochete cultures in BSK-II medium were inoculated from frozen glycerol stocks. Levels of antibiotics used are indicated in S1 Table. The spirochete cultures were grown at 35°C to a concentration between 1–5 x 107/ ml. Spirochetes were then diluted to 1 x 105/ml in 100 ml BSK-II medium and grown for 24 hours, followed by 48 hours growth with 1% BALB/c mouse blood (vol/vol) and 1x Borrelia antibiotic mixture (final concentrations of 20 μg/ml phosphomycin, 50 μg/ml rifampicin, and 2.5 μg/ml amphotericin B). The bacterial densities were not allowed to exceed 5 x 107/ml. Spirochetes were harvested by centrifugation at 6000xg for 15 minutes at 4°C and washed twice with 100 ml of cold phosphate-buffered saline (PBS). Mouse infection BALB/c or CD1d-/- mice were anesthetized by intraperitoneal injection of 200 mg/kg ketamine hydrochloride (Bimeda-MTC, Animal Health Inc., Cambridge, ON) and 10 mg/kg of xylazine hydrochloride (Bayer Inc., Toronto, ON). For vascular transmigration assays, anesthetized CD1d-/- mice were secured in a mouse restrainer and inoculated by tail vein injection with 4 x 108 spirochetes in 150 μl of phosphate buffered saline (PBS). For vascular adhesion assays, anesthetized mice were intravenously injected with 4 x 108 spirochetes via a jugular vein catheter. Direct counts of spirochetes in plasma Mice were anesthetized as described above. Additional intraperitoneal injection of anesthetic was done as necessary to maintain anesthesia for the total duration of the procedure. For direct spirochete counts in the vascular transmigration assays, blood samples (35 μl, collected in an equal volume of 20mM sodium citrate) were taken from the saphenous or tail vein at five and 60 minutes post-inoculation. For counts in vascular adhesion assays, samples were collected at three and 18 minutes post-inoculation. Samples were drawn into glass capillary tubes, the bottom of the capillary tubes were blocked with vacuum grease and incubated vertically at 4°C overnight to allow separation of blood cells by gravity. The next day, the glass capillaries were cut with a diamond pencil near the white blood cell-plasma interphase and 25 μl of plasma was collected and centrifuged at 6000xg for 15 minutes at 4°C to pellet the spirochetes. The supernatant fluid was carefully decanted and discarded. The pellet was resuspended in 6 μl of PBS, diluted as necessary, and loaded on a Petroff-Hausser counting chamber and counted. Spirochete numbers for each mouse at a later time point (18 or 60 minutes post-inoculation) were expressed as a percentage of the spirochete numbers observed at an initial time point (3 or 5 minutes post-inoculation) for each individual mouse. Surgical preparation for jugular vein catheterization and knee intravital microscopy Deep surgical anesthesia in BALB/c or CD1d-/- mice was induced as described above and maintained by regular iv injections of anesthetic in sterile normal saline. A home-made catheter made of PE10 polyethylene tubing (I.D. 0.011" O.D. 0.024", Intramedic, Becton Dickinson and Company, Sparks, MD) was used as a jugular vein catheter. The catheter was connected to a 1ml syringe filled with 100 I.U. / ml of heparin in physiological saline solution. After confirmation of induction of surgical anesthesia, the knee was prepared for intravital microscopy as previously described [49]. The hair over the jugular vein area was clipped and the mouse was positioned in dorsal recumbency, and secured over a regulated heating pad. The skin was incised at the ventral cervical region right to the midline at the level of the clavicle bone. Under a dissection microscope, the right jugular vein was separated carefully from adjacent fat and connective tissues by blunt dissection and the anterior aspect of the jugular vein was tied with 4.0 surgical sutures and secured tightly to the imaging platform with surgical tape. A slightly bent 30½ G needle was inserted parallel in the jugular vein and the vein was slightly lifted up gently with help of the inserted needle. A PE10 polyethylene tube was introduced into the vein with simultaneous removal of the needle from the vein. The jugular vein patency was confirmed by withdrawal of blood in the tubing and the catheter was secured at cranial and distal locations with a double surgical knot around the vein. The jugular vein was used for maintaining the anesthesia level, injecting fluorescent antibodies, and injecting spirochetes. For knee preparation, the right hind limb was slightly flexed and secured to a home-made plastic knee holder using a surgical tie just above the metatarsal joint. The medial aspect of the knee joint was slightly oriented upwards, placed, and immobilized in the plastic knee holder. The hair was clipped, the area was swabbed with mineral oil, and the skin over the medial aspect of the knee joint was carefully removed by incision. The connective tissues over the exposed area was carefully removed without injuring blood vessels. The exposed area was always immersed in isotonic saline to keep it moist. A glass cover slip was positioned over the exposed joint area and secured to the knee-holder using vacuum grease. Spinning disk confocal intravital microscopy Spinning disk confocal microscopy was performed using an Olympus BX51W1 base (Olympus, Center Valley, PA) fitted with 10x/0.30 UPlanFLN air and 20x/0.95 XLUMPlanFI water immersion objectives. The microscope was equipped with a confocal light path (WaveFx, Quorum, Guelph, ON, Canada) based on a modified Yokogawa CSU-10 head (Yokogawa Electric Corporation, Tokyo, Japan). The mice were injected with antibodies immediately before i.v. inoculation with B. burgdorferi, which corresponded to roughly 10–20 minutes before imaging, depending upon the experiment. The endothelial cells were stained with phycoerythrin (PE)-conjugated anti-PECAM-1 (5 μg per mouse; clone MEC 13.1; BD Biosciences, Mississauga, ON) or PECAM-1 antibody (50 μg per mouse; clone MEC 13.3; BD Biosciences, Mississauga, ON) conjugated in-house to Alexa Fluor 555 (Invitrogen, Burlington, ON) or Alexa Fluor 594 anti-mouse CD31 (5 μg per mouse; clone MEC 13.3; BioLegend Inc, San Diego, CA). β 3 integrin staining was achieved using Alexa Fluor 647 anti-mouse/rat CD61 antibody (7.5 μg per mouse; clone 2C9.G2; BioLegend Inc, San Diego, CA). The spirochetes were engineered for GFP expression as described earlier. Vascular transmigration was evaluated by exciting the fluorophores with two laser wavelengths (488 nm and 561 nm; Cobolt, Stockholm, Sweden) and visualizing with proper band-pass filters (Semrock, Rochester, NY). A back-thinned electron-multiplying charged-coupled device camera (512 x 512 pixels; C9100-13, Hamamatsu, Bridgewater, NJ, USA) was utilized for detecting emitted fluorescence. Volocity software (version 6.0.1, Improvision, Lexington, MA) was used to control the microscope, image acquisition, and analysis. The sensitivity settings for the red and green laser used was 255 with the autocontrast setting turned on. All laser power settings were set to the highest, i.e. 1.84 mv. For video acquisition, the shutter setting was selected as ‘do not manage shutters’ and binning settings were set to 2x for GFP and RFP channels, which allowed data acquisition at a rate of between 14–20 frames per second. Intravital vascular transmigration assay The vascular transmigration assay for B. burgdorferi was done in deeply anesthetized CD1d-/- mice with the medial aspect of the knee surgically prepared for imaging as described above. For transmigration assays, the CD1d-/- mice were intravenously inoculated with spirochetes 1–24 hours before imaging as described above. Images were acquired using a 10x objective lens and spirochetes were counted manually in the field of view (FOV). The data were pooled from a total of 6–16 mice per group from two independent experiments. Five fields of view or more were counted for each mouse. Because of the variability of intravital results that can be observed in different experiments, all B. burgdorferi strains being compared were analyzed in the same intravital session (eg, in Fig 5 one mouse was analyzed for each B. burgdorferi strain in each intravital session). Intravital vascular adhesion assay The vascular adhesion assay was done in deeply anesthetized CD1d-/- mice with the medial aspect of the knee surgically prepared for imaging as described above. For vascular adhesion assays, BALB/c mice were intravenously inoculated via the jugular vein catheter with spirochetes 10 minutes before imaging. Vascular interactions were recorded 18–45 minutes post-inoculation from straight, unbranched post-capillary venules of 15–25 μm diameter in the knee. Videos were recorded through 20x/0.95 XLUMPlanFI water immersion objectives. Spirochete-vascular interactions were counted in a length of 100 μm along the blood vessel manually as described before [14–16]. Because of the variability of intravital results that can be observed in different experiments, all B. burgdorferi strains being compared were analyzed in the same intravital session (eg., in Fig 5 one mouse was analyzed for each B. burgdorferi strain in each intravital session). Statistics GraphPad Prism 5.0 (GraphPad Software Inc., San Diego, CA) was used for statistical data analysis. Error bars in all graphs denote the standard deviation. Statistical significance was computed for experiments as noted in each figure legend.

Supporting Information S1 Table. B. burgdorferi strains used. https://doi.org/10.1371/journal.ppat.1005333.s001 (DOCX) S1 Video. Spinning disk confocal intravital microscopy footage of fluorescent B. burgdorferi transmigrated into knee joint-proximal tissue of Cd1d-/- mice. Experimental conditions are as per Figs 2–4. The video was captured 24 hours after tail vein injection of each mouse with 4x108 GFP-expressing B. burgdorferi (GCB726). The vasculature was counterstained with Alexa Fluor 555-conjugated PECAM-1 antibody. Elapsed time is shown at the top right and the scale is at the bottom left. https://doi.org/10.1371/journal.ppat.1005333.s002 (MOV) S2 Video. Spinning disk confocal intravital microscopy footage of fluorescent B. burgdorferi transmigrated into knee joint-proximal tissue of Cd1d-/- mice. Experimental conditions are as per Figs 2–4. The video was captured 24 hours after tail vein injection of each mouse with 4x108 GFP-expressing B. burgdorferi (GCB726). The vasculature was counterstained with Alexa Fluor 555-conjugated PECAM-1 antibody. Elapsed time is shown at the top right and the scale is at the bottom left. https://doi.org/10.1371/journal.ppat.1005333.s003 (MOV)

Acknowledgments Intravital microscopy was performed in the Snyder Institute's Live Cell Imaging Facility. We would like to thank Dr. Katarzyna Stevens and Dr. Pina Colarusso for training and support with image acquisition and analysis and Genevieve Chaconas for technical support. We are grateful to Scott Samuels for providing the spectinomycin/streptomycin resistance cassette.

Author Contributions Conceived and designed the experiments: DK LCR MS JAC WYL PK JC GC. Performed the experiments: DK MS. Analyzed the data: DK GC. Contributed reagents/materials/analysis tools: LCR JAC WYL PK JC PM. Wrote the paper: DK GC.